Drreddys Laboratories reported INR68.61B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
ANI Pharmaceuticals USD 196.2M 25.27M Jun/2025
Aurora Cannabis CAD 118.24M 66.26M Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Canopy Growth CAD 94.22M 4.36M Jun/2025
Cipla INR 54.32B 687.8M Jun/2025
Corcept Therapeutics USD 167.76M 13.96M Jun/2025
Drreddys Laboratories INR 68.61B 3.74B Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Lonza CHF 3.09B 564M Dec/2024
Novartis USD 9.97B 1.02B Jun/2025
Pacira USD 170.87M 3.93M Jun/2025
Prestige Brands USD 177.77M 30.32M Jun/2025
Richter Gedeon HUF 153.02B 2.72B Sep/2024
Sun Pharmaceuticals INR 104.14B 1.45B Jun/2025
Supernus Pharmaceuticals USD 153.31M 892K Jun/2025
Teva Pharmaceutical Industries USD 3.28B 95M Jun/2025